KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

International Flavors & Fragrances (IFF) Cash & Equivalents (2016 - 2025)

International Flavors & Fragrances (IFF) has 17 years of Cash & Equivalents data on record, last reported at $590.0 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 25.8% year-over-year to $590.0 million; the TTM value through Dec 2025 reached $590.0 million, up 25.8%, while the annual FY2025 figure was $590.0 million, 25.8% up from the prior year.
  • Cash & Equivalents reached $590.0 million in Q4 2025 per IFF's latest filing, down from $816.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $935.0 million in Q2 2021 and bottomed at $469.0 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $655.5 million, with a median of $638.0 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: soared 101.39% in 2021, then crashed 39.14% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $711.0 million in 2021, then crashed by 32.07% to $483.0 million in 2022, then soared by 45.55% to $703.0 million in 2023, then crashed by 33.29% to $469.0 million in 2024, then increased by 25.8% to $590.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $590.0 million in Q4 2025, $816.0 million in Q2 2025, and $613.0 million in Q1 2025.